Filing Flows › Comparisons › FHTX vs SNDX
Foghorn Therapeutics vs Syndax Pharmaceuticals: FHTX and SNDX compared
Foghorn Therapeutics is the larger company: $83.5M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026). Foghorn Therapeutics is growing faster (+925% against +82% a year earlier). Foghorn Therapeutics is more profitable, with an operating margin of 67.8% against -50.3%.
Where the money goes: FHTX and SNDX
Foghorn Therapeutics (FHTX) · Q3 2026
Foghorn Therapeutics, Q3 2026: revenue $83.5M (+925% year over year), operating margin 67.8%, net earnings $58.1M, operating cash flow −$18.2M. The chart follows the revenue to costs, profit and cash.
Syndax Pharmaceuticals (SNDX) · Q3 2026
Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.
| Foghorn Therapeutics (FHTX) | Syndax Pharmaceuticals (SNDX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $83.5M | $83.3M |
| Revenue growth, Y/Y | +925% | +82% |
| Operating margin | 67.8% | -50.3% |
| Net earnings | $58.1M | −$49.4M |
| Net margin | 69.6% | -59.3% |
| Operating cash flow | −$18.2M | −$27.3M |
| Market value | $132M | $1.3B |
| Analysts’ mean target | $4.17 | $35.45 |
Where the revenue comes from
Syndax Pharmaceuticals
- Product: $60.7M (73%)
- Collaboration Revenue: $22.6M (27%)
Questions
Which is bigger, Foghorn Therapeutics or Syndax Pharmaceuticals?
Foghorn Therapeutics is the larger company: $83.5M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026).
Is Foghorn Therapeutics or Syndax Pharmaceuticals growing faster?
Foghorn Therapeutics is growing faster (+925% against +82% a year earlier).
Which is more profitable, Foghorn Therapeutics or Syndax Pharmaceuticals?
Foghorn Therapeutics is more profitable, with an operating margin of 67.8% against -50.3%.
More: Foghorn Therapeutics earnings · how Foghorn Therapeutics makes money · Syndax Pharmaceuticals earnings · how Syndax Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.